These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28816054)

  • 1. Animal 'models': How a mechanistic approach can reduce suffering and improve translatability.
    Lilley E
    Altern Lab Anim; 2017 Jul; 45(3):159-160. PubMed ID: 28816054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Reproducibility to Translation in Neurodegenerative Disease.
    Zeiss CJ
    ILAR J; 2017 Jul; 58(1):106-114. PubMed ID: 28444192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translatability score revisited: differentiation for distinct disease areas.
    Wendler A; Wehling M
    J Transl Med; 2017 Nov; 15(1):226. PubMed ID: 29100553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From bench to bedside and to health policies: ethics in translational research.
    Petrini C
    Clin Ter; 2011; 162(1):51-9. PubMed ID: 21448547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral studies on anxiety and depression in a drug discovery environment: keys to a successful future.
    Bouwknecht JA
    Eur J Pharmacol; 2015 Apr; 753():158-76. PubMed ID: 25460021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multifactorial role of the 3Rs in shifting the harm-benefit analysis in animal models of disease.
    Graham ML; Prescott MJ
    Eur J Pharmacol; 2015 Jul; 759():19-29. PubMed ID: 25823812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Animal experimentation and progress in medicine].
    Pons JM; Permanyer-Miralda G; Camí J; Rodés J
    Med Clin (Barc); 2014 Nov; 143(10):448-54. PubMed ID: 24854194
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development.
    Kamal MA; Greig NH
    Curr Pharm Des; 2016; 22(5):515-7. PubMed ID: 26825465
    [No Abstract]   [Full Text] [Related]  

  • 9. Animal models of human disease: challenges in enabling translation.
    McGonigle P; Ruggeri B
    Biochem Pharmacol; 2014 Jan; 87(1):162-71. PubMed ID: 23954708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Structured Approach to Optimizing Animal Model Selection for Human Translation: The Animal Model Quality Assessment.
    Storey J; Gobbetti T; Olzinski A; Berridge BR
    ILAR J; 2021 Dec; 62(1-2):66-76. PubMed ID: 35421235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational challenges of animal models in Chagas disease drug development: a review.
    Chatelain E; Konar N
    Drug Des Devel Ther; 2015; 9():4807-23. PubMed ID: 26316715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of translatability in drug discovery.
    Rezaee R; Abdollahi M
    Expert Opin Drug Discov; 2017 Mar; 12(3):237-239. PubMed ID: 28095719
    [No Abstract]   [Full Text] [Related]  

  • 13. Bedside to Bench: Integrating Quantitative Clinical Pharmacology and Reverse Translation to Optimize Drug Development.
    Gibbs JP; Menon R; Kasichayanula S
    Clin Pharmacol Ther; 2018 Feb; 103(2):196-198. PubMed ID: 29105747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From bench to patient: model systems in drug discovery.
    Breyer MD; Look AT; Cifra A
    Dis Model Mech; 2015 Oct; 8(10):1171-4. PubMed ID: 26438689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translatability scoring in drug development: eight case studies.
    Wendler A; Wehling M
    J Transl Med; 2012 Mar; 10():39. PubMed ID: 22397594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson's disease.
    Zeiss CJ; Allore HG; Beck AP
    PLoS One; 2017; 12(2):e0171790. PubMed ID: 28182759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connecting Brain Proteomics with Behavioural Neuroscience in Translational Animal Models of Neuropsychiatric Disorders.
    Sarnyai Z; Guest PC
    Adv Exp Med Biol; 2017; 974():97-114. PubMed ID: 28353227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse translation of failed treatments can help improving the validity of preclinical animal models.
    't Hart BA
    Eur J Pharmacol; 2015 Jul; 759():14-8. PubMed ID: 25823810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will models of naturally occurring disease in animals reduce the bench-to-bedside gap in biomedical research?
    Manuel B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jan; 25(1):5-7. PubMed ID: 23611088
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug discovery for CNS disorders: from bench to bedside.
    Kazantsev AG; Outeiro TF
    CNS Neurol Disord Drug Targets; 2010 Dec; 9(6):668. PubMed ID: 20942783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.